Johne's disease

The team will employ reverse vaccinology coupled with high-throughput genomics approaches, such as RNA-seq, to deliver the new vaccines within four years.

Life Technologies said this week that it has signed an agreement with Copan Flock to provide an integrated, end-to-end system for DNA forensics.

NEW YORK (GenomeWeb News) – GeneThera announced today that its wholly owned subsidiary Applied Genetics has signed a deal with the Universidad National Autonoma de Mexico to validate GeneThera's platform for Johne's disease.

GeneThera is currently negotiating formal licensing agreements with the Universita di Roma "Tor Vegata" and Universita Cattolica del Sacro Cuore, which have jointly developed a potential liposome-based therapeutic for Johne's disease, an uncurable bacterial disease affecting the intestinal tract of livestock.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.